Detalhe da pesquisa
1.
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.
Cancer
; 128(15): 2949-2957, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593736
2.
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol.
BMC Pediatr
; 19(1): 31, 2019 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684955
3.
Activation of dopamine D4 receptors is protective against hypoxia/reoxygenation-induced cell death in HT22 cells.
J Pharmacol Sci
; 114(2): 217-24, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20921819